Home » Topics » BioWorld Science

BioWorld Science
RSS

New ALK kinase inhibitors revealed in University of Michigan patent

Oct. 9, 2019

Hinova Pharmaceuticals details compounds for cancer

Oct. 9, 2019

Pfizer identifies antibacterial agents

Oct. 9, 2019

University of California discloses new VLA-2 antagonists

Oct. 9, 2019

U.S. researchers patent ATR kinase inhibitors

Oct. 9, 2019

Faron receives DMC feedback for phase I/II MATINS trial of Clevegen

Oct. 9, 2019

GSK and Lyell Immunopharma collaborate to improve cell therapies for cancer

Oct. 9, 2019

Scenesse wins approval in U.S. for erythropoietic protoporphyria

Oct. 9, 2019

Tezepelumab reduces activation of matrix remodeling and inflammatory pathways

Oct. 9, 2019

FDA approves Wilate for hemophilia A

Oct. 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...